Immix granted FDA nod to start U.S. trial for cell therapy
Post Content
Similar Posts
Nasdaq, S&P, Dow gain a day ahead of Thanksgiving; yields rise, oil tumbles
Post Content Post Views: 132
Timbercreek Financial Corp. declares $0.0575 dividend
Post Content Post Views: 123
Column-Fed starting gun for $6 trillion dash from cash: McGeever
Post Content Post Views: 130
Judge set to rule on Berkshire Hathaway request for speedy trial over Pilot unit
Post Content Post Views: 109
Crypto investors cheer talk of Binance criminal probe resolution
Post Content Post Views: 136
British Business Bank unveils £130m fund to boost Welsh SMEs
Post Content Post Views: 117